Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

被引：265
作者：
Casali, Paolo G.
Blay, Jean-Yves
Bertuzzi, Alexia
Bielack, Stefan
Bjerkehagen, Bodil
Bonvalot, Sylvie
Boukovinas, Ioannis
Bruzzi, Paolo
Dei Tos, Angelo Paolo
Dileo, Palma
Eriksson, Mikael
Fedenko, Alexander
Ferrari, Andrea
Ferrari, Stefano
Gelderblom, Hans
Grimer, Robert
Gronchi, Alessandro
Haas, Rick
Hall, Kirsten Sundby
Hohenberger, Peter
Issels, Rolf
Joensuu, Heikki
Judson, Ian
Le Cesne, Axel
Litiere, Saskia
Martin-Broto, Javier
Merimsky, Ofer
Montemurro, Michael
Morosi, Carlo
Picci, Piero
Ray-Coquard, Isabelle
Reichardt, Peter
Rutkowski, Piotr
Schlemmer, Marcus
Stacchiotti, Silvia
Torri, Valter
Trama, Annalisa
Van Coevorden, Frits
Van der Graaf, Winette
Vanel, Daniel
Wardelmann, Eva
机构：
来源：
ANNALS OF ONCOLOGY | 2014年 / 25卷
关键词：
PHASE-II TRIAL; NEOADJUVANT/ADJUVANT IMATINIB MESYLATE; RANDOMIZED-TRIAL; ADJUVANT IMATINIB; CARNEY-STRATAKIS; DOSE IMATINIB; SURGERY; PROGRESSION; RECURRENCE; MUTATIONS;
D O I：
10.1093/annonc/mdu255
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：21 / 26
页数：6
相关论文
共 41 条
[1]  
[Anonymous], 2010, J CLIN ONCOL, V28, P1247
[2]   Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib - Analysis of prognostic factors (EORTC-STBSG collaborative study) [J].
Bauer, S. ;
Rutkowski, P. ;
Hohenberger, P. ;
Miceli, R. ;
Fumagalli, E. ;
Siedlecki, J. A. ;
Nguyen, B. -P. ;
Kerst, M. ;
Fiore, M. ;
Nyckowski, P. ;
Hoiczyk, M. ;
Cats, A. ;
Casali, P. G. ;
Treckmann, J. ;
van Coevorden, F. ;
Gronchi, A. .
EJSO, 2014, 40 (04) :412-419
[3]   Long-term results from a randomized phase II trial of standard- versus higher-dose imatinib mesylate for patients with unresectable or metastatic gastrointestinal stromal tumors expressing KIT [J].
Blanke, Charles D. ;
Demetri, George D. ;
von Mehren, Margaret ;
Heinrich, Michael C. ;
Eisenberg, Burton ;
Fletcher, Jonathan A. ;
Corless, Christopher L. ;
Fletcher, Christopher D. M. ;
Roberts, Peter J. ;
Heinz, Daniela ;
Wehre, Elisabeth ;
Nikolova, Zariana ;
Joensuu, Heikki .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :620-625
[4]   Phase III randomized, intergroup trial assessing imatinib mesylate at two dose levels in patients with unresectable or metastatic gastrointestinal stromal tumors expressing the kit receptor tyrosine kinase: S0033 [J].
Blanke, Charles D. ;
Rankin, Cathryn ;
Demetri, George D. ;
Ryan, Christopher W. ;
von Mehren, Margaret ;
Benjamin, Robert S. ;
Raymond, A. Kevin ;
Bramwell, Vivien H. C. ;
Baker, Laurence H. ;
Maki, Robert G. ;
Tanaka, Michael ;
Hecht, J. Randolph ;
Heinrich, Michael C. ;
Fletcher, Christopher D. M. ;
Crowley, John J. ;
Borden, Ernest C. .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (04) :626-632
[5]   Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: Proposal of new computed tomography response criteria [J].
Choi, Haesun ;
Charnsangavej, Chuslip ;
Faria, Silvana C. ;
Macapinlac, Homer A. ;
Burgess, Michael A. ;
Patel, Shreyaskumar R. ;
Chen, Lei L. ;
Podoloff, Donald A. ;
Benjamin, Robert S. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (13) :1753-1759
[6]   KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours [J].
Debiec-Rychter, Maria ;
Sciot, Raf ;
Le Cesne, Axel ;
Schlemmer, Marcus ;
Hohenberger, Peter ;
van Oosterom, Allan T. ;
Blay, Jean-Yves ;
Leyvraz, Serge ;
Stul, Michel ;
Casali, Paolo G. ;
Zalcberg, John ;
Verweij, Jaap ;
Van Glabbeke, Martine ;
Hagemeijer, Anne ;
Judson, Ian .
EUROPEAN JOURNAL OF CANCER, 2006, 42 (08) :1093-1103
[7]   Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial [J].
DeMatteo, Ronald P. ;
Ballman, Karla V. ;
Antonescu, Cristina R. ;
Maki, Robert G. ;
Pisters, Peter W. T. ;
Demetri, George D. ;
Blackstein, Martin E. ;
Blanke, Charles D. ;
von Mehren, Margaret ;
Brennan, Murray F. ;
Patel, Shreyaskumar ;
McCarter, Martin D. ;
Polikoff, Jonathan A. ;
Tan, Benjamin R. ;
Owzar, Kouros .
LANCET, 2009, 373 (9669) :1097-1104
[8]   Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial [J].
Demetri, George D. ;
van Oosterom, Allan T. ;
Garrett, Christopher R. ;
Blackstein, Martin E. ;
Shah, Manisha H. ;
Verweij, Jaap ;
McArthur, Grant ;
Judson, Ian R. ;
Heinrich, Michael C. ;
Morgan, Jeffrey A. ;
Desai, Jayesh ;
D Fletcher, Christopher ;
George, Suzanne ;
Bello, Carlo L. ;
Huang, Xin ;
Baum, Charles M. ;
Casali, Paolo G. .
LANCET, 2006, 368 (9544) :1329-1338
[9]   Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial [J].
Demetri, George D. ;
Reichardt, Peter ;
Kang, Yoon-Koo ;
Blay, Jean-Yves ;
Rutkowski, Piotr ;
Gelderblom, Hans ;
Hohenberger, Peter ;
Leahy, Michael ;
von Mehren, Margaret ;
Joensuu, Heikki ;
Badalamenti, Giuseppe ;
Blackstein, Martin ;
Le Cesne, Axel ;
Schoffski, Patrick ;
Maki, Robert G. ;
Bauer, Sebastian ;
Binh Bui Nguyen ;
Xu, Jianming ;
Nishida, Toshirou ;
Chung, John ;
Kappeler, Christian ;
Kuss, Iris ;
Laurent, Dirk ;
Casali, Paolo G. .
LANCET, 2013, 381 (9863) :295-302
[10]   Imatinib Plasma Levels Are Correlated With Clinical Benefit in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors [J].
Demetri, George D. ;
Wang, Yanfeng ;
Wehrle, Elisabeth ;
Racine, Amy ;
Nikolova, Zariana ;
Blanke, Charles D. ;
Joensuu, Heikki ;
von Mehren, Margaret .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (19) :3141-3147
12345